|
|
 |
|
TEVA: Teva Pharma Ind Ltd Ads - Stock News |
Enter Ticker:
|
|
| Nov 17, 2009 |
BenchmarkJournal.com Receives Analysis on TRMB, TFSL, TEVA, DRIV,UNTD and AMMD |
| Nov 13, 2009 |
Teva Pharmaceutical (TEVA) Could Be Approaching New 52-Week High |
| Nov 13, 2009 |
Teva Gets Final OK for Generic Prevacid Delayed-Release Capsules |
| Nov 12, 2009 |
Teva Gets Court Decision Regarding Generic Prevacid SoluTab |
| Nov 11, 2009 |
BiomedReports: News and FDA Updates for Teva (Nasdaq:TEVA), Vertex (Nasdaq:VRTX) |
| Nov 11, 2009 |
BiomedReports: News and FDA Updates for Sigma-Aldrich (Nasdaq:SIAL), Teva (Nasdaq:TEVA) |
| Nov 10, 2009 |
Teva Receives Final Approval for Generic Prevacid(R) Delayed-Release Capsules |
| Nov 10, 2009 |
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 10, 2009 : TEVA, ITWO, FNFG and ATVI |
| Nov 10, 2009 |
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab |
| Nov 10, 2009 |
Market Watch: Sunwin International Neutraceuticals - November 10,2009 |
| Nov 10, 2009 |
Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents |
| Nov 05, 2009 |
Teva Releases Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets |
| Nov 05, 2009 |
Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services, Teva Pharmaceutical Industries Ltd., Mylan and Comcast Corp. |
| Nov 05, 2009 |
Teva Reports Strong Quarter |
| Nov 05, 2009 |
BiomedReports: News and FDA Updates for ZIOPHARM (Nasdaq:ZIOP), Teva (NASDAQ:TEVA), Aetna (NYSE:AET) |
| |
| ZACKS COMMENTARY FOR TEVA |
| Nov 09, 2009 | Zacks Equity Research: Report for TEVA | | Nov 05, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services, Teva Pharmaceutical Industries Ltd., Mylan and Comcast Corp. | | Nov 04, 2009 | Zacks Blog: Teva Reports Strong Quarter | | Oct 28, 2009 | Zacks Blog: Cephalon Beats, Provides Outlook | | Oct 27, 2009 | Zacks Blog: BioMarin Purchases Huxley | | Oct 23, 2009 | Zacks Blog: CEPH’s Nuvigil Faces Generic Threat | | Oct 02, 2009 | Zacks Blog: Jobs Stabilizing; Recovery Hurts | | Oct 01, 2009 | Zacks Blog: Campath Meets Primary Endpoint | | Sep 30, 2009 | Zacks Blog: Good News for Novartis | | Sep 29, 2009 | Zacks Blog: Nuvigil Granted Priority Review | | Sep 29, 2009 | Zacks Blog: Merck Serono MS Study Halted | | Sep 16, 2009 | Zacks Blog: Teva’s Copaxone Challenged |
|
|
Sponsored Links 
-0.32